Prentiss Smith & Co’s Meridian Bioscience Inc VIVO Stock Holding History

Prentiss Smith & Co’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$3K	–	245
2018 Q3	$3K	Hold	200	–	–	﹤0.01%	245
2018 Q2	$3K	Hold	200	–	–	﹤0.01%	252
2018 Q1	$3K	Hold	200	–	–	﹤0.01%	263
2017 Q4	$3K	Hold	200	–	–	﹤0.01%	279
2017 Q3	$3K	Hold	200	–	–	﹤0.01%	229
2017 Q2	$3K	Hold	200	–	–	﹤0.01%	236
2017 Q1	$3K	Hold	200	–	–	﹤0.01%	228
2016 Q4	$4K	Hold	200	–	–	﹤0.01%	234
2016 Q3	$4K	Hold	200	–	–	﹤0.01%	228
2016 Q2	$4K	Hold	200	–	–	﹤0.01%	241
2016 Q1	$4K	Hold	200	–	–	﹤0.01%	277
2015 Q4	$4K	Hold	200	–	–	﹤0.01%	290
2015 Q3	$3K	Hold	200	–	–	﹤0.01%	291
2015 Q2	$4K	Hold	200	–	–	﹤0.01%	258
2015 Q1	$4K	Hold	200	–	–	﹤0.01%	279
2014 Q4	$3K	Hold	200	–	–	﹤0.01%	293
2014 Q3	$4K	Hold	200	–	–	﹤0.01%	219
2014 Q2	$4K	Sell	200 -200	-50%	-$4.11K	﹤0.01%	218
2014 Q1	$9K	Hold	400	–	–	﹤0.01%	211
2013 Q4	$11K	Hold	400	–	–	0.01%	198
2013 Q3	$9K	Hold	400	–	–	﹤0.01%	195
2013 Q2	$9K	Buy	+400	New	+$8.63K	﹤0.01%	206

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Prentiss Smith & Co's VIVO Position: Q4 2018 in Review

Prentiss Smith & Co sold out of Meridian Bioscience Inc (VIVO) in Q4 2018, closing a stake of 200 shares — an estimated $3K sold.

Prentiss Smith & Co first reported a position in VIVO in Q2 2013 and held it in 22 quarters. The position peaked at $11K in Q4 2013. 191 funds tracked by Wall St. Rank hold VIVO as of Q4 2018.

Prentiss Smith & Co reported no remaining Meridian Bioscience Inc position as of Q4 2018 after selling out during the quarter.
Prentiss Smith & Co sold 200 Meridian Bioscience Inc shares in Q4 2018, an estimated $3K.
Prentiss Smith & Co first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 22 quarters.
Prentiss Smith & Co's Meridian Bioscience Inc position peaked at $11K in Q4 2013.
191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2018.

Based on Prentiss Smith & Co's 13F filing for Q4 2018, filed 15 Jan 2019.